Interferon Is Superior to Direct Acting Antiviral Therapy in Tertiary Prevention of Early Recurrence of Hepatocellular Carcinoma

The elimination of chronic hepatitis C infection (CHC) by pegylated interferon plus ribavirin (Peg-IFN/RBV) decreases hepatocellular carcinoma (HCC) recurrence rate. However, the tertiary prevention of HCC recurrence by direct acting antiviral agents (DAA) remains controversial. This study aims to c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Teng, Wei, Jeng, Wen-Juei, Yang, Hwai-I, Chen, Wei-Ting, Hsieh, Yi-Chung, Huang, Chien-Hao, Lin, Chen-Chun, Lin, Chun-Yen, Lin, Shi-Ming, Sheen, I-Shyan
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7016942/
https://ncbi.nlm.nih.gov/pubmed/31861706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados